Newsletter | April 23, 2024

04.23.24 -- FDA Warns Industry Of Fraudulent & Unreliable Lab Testing Data In Premarket Submissions

FEATURED EDITORIAL

FDA Warns Industry Of Fraudulent & Unreliable Lab Testing Data In Premarket Submissions

The FDA recently announced that they have seen an increase in the number of entities that contract out testing or services where the data provided by said firms was fabricated, duplicated, or just deemed “unreliable.” Here's what you can do.

AI And Pharmaceutical Development: WHO Calls For Ethical Framework, Good Governance

The World Health Organization (WHO) recently released a document titled Benefits and risks of using artificial intelligence for pharmaceutical development and delivery describing the ethical issues and governance considerations for using AI in drug discovery, preclinical development, and clinical trials.

MOST POPULAR NEWS

QuidelOrtho Adds Fentanyl Test To Its Vitros Systems As A MicroTip Partnership Assay

New Diagnostic Tool Achieves Accuracy Of PCR Tests With Faster & Simpler Nanopore System

Labcorp Receives FDA Emergency Use Authorization For Mpox PCR Test Home Collection Kit

ADLM Finds That FDA's Proposed Lab Developed Tests Rule Would Hinder Pediatric Care

Nanostics & AHS Collaborate To Develop New Diagnostic Tools For Urological Diseases

Predicine Introduces PredicineCARE NGS Kit

Dotmatics Luma Lab Connect Unlocks The Untapped Value Of Lab Instrument Data

SOPHiA GENETICS Announces Unilabs Is Using Its AI Technology To Detect HRD

Sebia Receives U.S. FDA Clearance For The CAPILLARYS 3 DBS Devices

Waters Launches Alliance iS Bio HPLC System To Help Biopharma QC Labs Increase Efficiency

Thermo Fisher Scientific Launches New ENERGY STAR Certified TSX Universal Series ULT Freezers